These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14764658)

  • 1. Potassium canrenoate, an aldosterone receptor antagonist, reduces isoprenaline-induced cardiac fibrosis in the rat.
    Bos R; Mougenot N; Médiani O; Vanhoutte PM; Lechat P
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1160-6. PubMed ID: 14764658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of kappa-opioid receptor reduces isoprenaline-induced cardiac hypertrophy and fibrosis.
    Yin W; Zhang P; Huang JH; Zhang QY; Fan R; Li J; Zhou JJ; Hu YZ; Guo HT; Zhang SM; Wang YM; Kaye AD; Gu CH; Liu JC; Cheng L; Cui Q; Yi DH; Pei JM
    Eur J Pharmacol; 2009 Apr; 607(1-3):135-42. PubMed ID: 19233160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldosterone receptor blockade inhibits increased furosemide-sensitive sodium reabsorption in rats with liver cirrhosis.
    Jonassen TE; Petersen JS; Sørensen AM; Andreasen F; Christensen S
    J Pharmacol Exp Ther; 1998 Dec; 287(3):931-6. PubMed ID: 9864275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of thalidomide on isoprenaline-induced acute myocardial injury: a haemodynamic, histopathological and ultrastructural study.
    Loh HK; Sahoo KC; Kishore K; Ray R; Nag TC; Kumari S; Arya DS
    Basic Clin Pharmacol Toxicol; 2007 Apr; 100(4):233-9. PubMed ID: 17371527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac, neuroadrenergic, and portal hemodynamic effects of prolonged aldosterone blockade in postviral child A cirrhosis.
    Pozzi M; Grassi G; Ratti L; Favini G; Dell'Oro R; Redaelli E; Calchera I; Boari G; Mancia G
    Am J Gastroenterol; 2005 May; 100(5):1110-6. PubMed ID: 15842586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
    Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
    Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute aldosterone antagonism improves cardiac vagal control in humans.
    Fletcher J; Buch AN; Routledge HC; Chowdhary S; Coote JH; Townend JN
    J Am Coll Cardiol; 2004 Apr; 43(7):1270-5. PubMed ID: 15063441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-course reduction of renal function in rats on high sodium intake: acute reversal by potassium canrenoate.
    Rugale C; Cordaillat M; Mimran A; Jover B
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):412-5. PubMed ID: 18307731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Extrarenal effects of potassium-canrenoate. Haemodynamic investigations during neuroleptanalgesia in cardiosurgical patients (author's transl)].
    Piepenbrock S; Hempelmann G; Schwarz S; Oelert H
    Anaesthesist; 1979 Apr; 28(4):163-70. PubMed ID: 312042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure.
    Dieterich HA; Wendt C; Saborowski F
    Fiziol Cheloveka; 2005; 31(6):97-105. PubMed ID: 16366159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical study of the efficacy of oral potassium canrenoate and spironolactone in essential arterial hypertension].
    Tosti-Croce C; Mantellini R; Fanti P; Sciarra F
    Minerva Med; 1983 Apr; 74(14-15):791-7. PubMed ID: 6339999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of canrenoate plus angiotensin-converting enzyme inhibitors versus angiotensin-converting enzyme inhibitors alone on systolic and diastolic function in patients with acute anterior myocardial infarction.
    Di Pasquale P; Cannizzaro S; Scalzo S; Parrinello G; Fasullo S; Giambanco F; Fatta A; Paterna S
    Am Heart J; 2005 Nov; 150(5):919. PubMed ID: 16290961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Galectin-3 Pathway Prevents Isoproterenol-Induced Left Ventricular Dysfunction and Fibrosis in Mice.
    Vergaro G; Prud'homme M; Fazal L; Merval R; Passino C; Emdin M; Samuel JL; Cohen Solal A; Delcayre C
    Hypertension; 2016 Mar; 67(3):606-12. PubMed ID: 26781273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of catecholamine-induced cardiac fibrosis by an aldosterone antagonist.
    Bos R; Mougenot N; Findji L; Médiani O; Vanhoutte PM; Lechat P
    J Cardiovasc Pharmacol; 2005 Jan; 45(1):8-13. PubMed ID: 15613973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amlodipine decreases fibrosis and cardiac hypertrophy in spontaneously hypertensive rats: persistent effects after withdrawal.
    Sevilla MA; Voces F; Carrón R; Guerrero EI; Ardanaz N; San Román L; Arévalo MA; Montero MJ
    Life Sci; 2004 Jul; 75(7):881-91. PubMed ID: 15183079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized clinical study of the efficacy of amiloride and potassium canrenoate in nonazotemic cirrhotic patients with ascites.
    Angeli P; Dalla Pria M; De Bei E; Albino G; Caregaro L; Merkel C; Ceolotto G; Gatta A
    Hepatology; 1994 Jan; 19(1):72-9. PubMed ID: 8276370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cardiovascular and ionic changes in pathogenesis and prevention of isoprenaline-induced cardiac necrosis.
    Strubelt O; Siegers CP
    Recent Adv Stud Cardiac Struct Metab; 1975; 6():135-42. PubMed ID: 741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central infusion of aldosterone synthase inhibitor attenuates left ventricular dysfunction and remodelling in rats after myocardial infarction.
    Huang BS; White RA; Ahmad M; Tan J; Jeng AY; Leenen FH
    Cardiovasc Res; 2009 Feb; 81(3):574-81. PubMed ID: 18689429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to nor-epinephrine, isoprenaline and spironolactone derivatives in normal and hypertensive rats.
    Eandi M; Ricci Gamalero S; Miocchi D
    Boll Soc Ital Biol Sper; 1979 Jul; 55(13):1252-8. PubMed ID: 508422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
    Gao S; Long CL; Wang RH; Wang H
    Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.